Osteoporosis drugs like Actonel, Boniva, and Fosamax could double the risk of esophageal cancer if they are used over a long period of time, according to the findings from a new study. The research, which was funded by Britain’s Medical Research Council and Cancer Research UK, was published today in the British Medical Journal. Actonel, [...]

Verdicts, judgments and cases that made the news the week of June 21, 2010.

Around the Web, there are several stories related to health, safety, injury avoidance as well as consumer news on this Tuesday. Enjoy!! Actos Less Risky than Avandia A new study finds there is no increased risk of stroke or heart attack or death from taking the diabetes drug Avandia, contract to recent research Airline Kitchen Food Cited as Unsanitary, Unsafe Numerous catering facilities have ...

A New York jury has ordered Merck & Co. to pay $8 million to a former Fosamax user who claimed she developed osteonecrosis of the jaw (ONJ), or dead jaw syndrome, from taking the osteoporosis drug. The award was $3 million more than plaintiff Shirley Boles had asked for in her lawsuit. Merck has [...]

Reporting in the journal Urology, researchers at Thomas Jefferson University have found that a pre-emptive multimodal pain regimen that included pregabalin (Lyrica) decreased the use of opioid analgesics in patients undergoing robotic-assisted laparoscopic radical prostatectomy.

Hospital for Special Surgery announced the receipt of a $5 million commitment from CA Technologies, an IT management software and solutions company, at its 27th Annual Tribute Dinner at the Waldorf Astoria on June 21, 2010.

Deutsche Bank AG salesman Jon-Paul Rorech didn’t illegally disclose information on a bond sale to a hedge-fund manager, a judge ruled in U.S. regulators’ first lawsuit alleging insider trading of credit-default swaps.

NEW YORK (Reuters) - A jury on Friday awarded $8 million in compensatory damages to a Florida woman who sued Merck & Co, alleging the company's osteoporosis drug Fosamax damaged her jaw, nine months after the first lawsuit ended in a mistrial.

NEW YORK (Reuters) - A jury on Friday awarded $8 million in compensatory damages to a Florida woman who sued Merck & Co, alleging the company's osteoporosis drug Fosamax damaged her jaw, nine months after the first lawsuit ended in a mistrial.

NEW YORK (Reuters) - A jury on Friday awarded $8 million in compensatory damages to a Florida woman who sued Merck & Co, alleging the company's osteoporosis drug Fosamax damaged her jaw, nine months after the first lawsuit ended in a mistrial.